Rigontec
Latest round
- Series A
Last raised
- Sep 2016
Total raised
- $34M
Investors
- 7
About Rigontec
Established in 2014 and based in Bonn, Germany, Rigontec GmbH operates as a biopharmaceutical company that develops 3pRNA-based immunotherapeutics for the treatment of cancer and viral diseases.
Who invested in Rigontec
7 investors across 3 rounds
See all investors in Rigontec
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Rigontec
Who invested in Rigontec?
Rigontec has 7 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Rigontec raised?
Rigontec has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Rigontec last raise money?
Rigontec's most recent round on record is a Series A, in Sep 2016.
What does Rigontec do?
Established in 2014 and based in Bonn, Germany, Rigontec GmbH operates as a biopharmaceutical company that develops 3pRNA-based immunotherapeutics for the treatment of cancer and viral diseases.
Where is Rigontec headquartered?
Rigontec is headquartered in Munich, Germany.
Which VCs invest in companies like Rigontec?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at Rigontec's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Rigontec? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.